Glomerular function time trends in long-term survivors of childhood cancer: A longitudinal study

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 10, 2013, Pages 1736-1746

  Mulder, Renee L ^a   Knijnenburg, Sebastiaan L ^a   Geskus, Ronald B ^b   Van Dalen, Elvira C ^a   Van Der Pal, Helena J H ^a,c   Koning, Caro C E ^d   Bouts, Antonia H ^a   Caron, Huib N ^a   Kremer, Leontien C M ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Departments of Clinical Epidemiology   (Netherlands)

^c Departments of Medical Oncology   (Netherlands)

^d Departments of Radiation Oncology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOVASCULAR MORTALITY; CHILD; CHILDHOOD CANCER; CREATININE BLOOD LEVEL; DETERIORATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY FUNCTION; LONG TERM SURVIVAL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; NEOPLASMS; QUALITY OF LIFE; RISK FACTORS; SURVIVORS;

EID: 84886431529     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0036     Document Type: Article

References (33)

1. Curry HL, Parkes SE, Powell JE, Mann JR. Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer 2006;42: 501-8.
2. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009;45:992-1005.
3. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82.
4. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA2007;297: 2705-15.
5. Skinner R. Renal damage. In:Wallace H, Green DM, editors. Late effects of childhood cancer. London: Hodder Arnold; 2004. p. 125-37.
6. Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group. Pediatr Blood Cancer 2008;51:724-31.
7. Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. Eur J Cancer 2009;45:3213-9.
8. Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer 2010;54:983-9.
9. Pietila S, Ala-Houhala M, Lenko HL, Harmoinen AP, Turjanmaa V, Makipernaa A. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment. Pediatr Blood Cancer 2005;44:363-9.
10. English MW, Skinner R, Pearson AD, Price L, Wyllie R, Craft AW. Doserelated nephrotoxicity of carboplatin in children. Br J Cancer 1999;81: 336-41.
11. Frisk P, Bratteby LE, Carlson K, Lonnerholm G. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 2002;29:129-36.
12. Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, et al. Longterm evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 2009;27:5350-5.
13. Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 1998;77:1677-82.
14. Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group. Br J Cancer 2000;82:1636-45.
15. Gronroos MH, Jahnukainen T, Mottonen M, Perkkio M, Irjala K, Salmi TT. Long-term follow-up of renal function after high-dose methotrexate treatment in children. Pediatr Blood Cancer 2008;51:535-9.
16. Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, et al. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 1999;39:454-61.
17. de Graaf SS, van Gent H, Reitsma-Bierens WC, van Luyk WH, Dolsma WV, Postma A. Renal function after unilateral nephrectomy for Wilms' tumour: the influence of radiation therapy. Eur J Cancer 1996;32A: 465-9.
18. Knijnenburg SL, Jaspers MW, van der Pal HJ, Schouten-van Meeteren AY, Bouts AH, Lieverst JA, et al. Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol 2012;7:1416-27.
19. Brock PR, Koliouskas DE, Barratt TM, Yeomans E, Pritchard J. Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 1991;118: 531-4.
20. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-83.
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
22. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Int Med 2012;156:785-95.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
24. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976;31:155-63.
25. Carter JL, Stevens PE, Irving JE, Lamb EJ. Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age. QJM 2011;104:839-47.
26. Douville P, Martel AR, Talbot J, Desmeules S, Langlois S, Agharazii M. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant 2009;24:97-103.
27. Chevallier C, Hadj-Aissa A, Brunat-Mentigny M, Faraj G, Schell M, Cochat P. Renal function after nephrectomy for Wilms' tumor. Arch Pediatr 1997;4:639-44.
28. Makipernaa A, Koskimies O, Jaaskelainen J, Teppo AM, Siimes MA. Renal growth and function 11-28 years after treatment of Wilms' tumour. Eur J Pediatr 1991;150:444-7.
29. Schell M, Cochat P, Hadj-Aissa A, Bouffet E, Dubourg L, Brunat- Mentigny M. Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour. Pediatr Nephrol 1995;9: 579-82.
30. Skinner R, Pearson AD, Coulthard MG, Skillen AW, Hodson AW, Goldfinch ME, et al. Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 1991; 28:81-92.
31. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006;52:5-18.
32. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375: 2073-81.
33. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-37.